Gel-clot Assay

Bacterial endotoxin, particularly lipopolysaccharide from Gram-negative bacteria, activates Factor C in horseshoe crab amebocyte lysate. That activation drives downstream enzyme steps rather than producing the readout directly. The cascade ultimately converts soluble coagulogen into insoluble material, creating the firm gel that serves as the assay’s visible endpoint.

Coagulogen provides the soluble precursor that the activated enzyme cascade transforms into an insoluble gel. This chemical change links endotoxin recognition to an observable physical outcome. Because the result can be recorded as clot formation or no clot after incubation, the assay translates molecular activation into a practical decision about whether endotoxin exceeds a defined limit.

Serial dilutions allow the sample to be examined across progressively changed concentrations rather than at one condition alone. The resulting pattern can support a semi-quantitative assessment of endotoxin, while the clot or no-clot endpoint still provides the basic threshold interpretation. This is useful when a sample’s endotoxin level must be evaluated relative to a defined limit.

Incubation provides the period during which endotoxin-triggered enzymatic reactions can proceed through the lysate coagulation cascade. Afterward, the sample is assessed for formation of a firm clot. A clot indicates that endotoxin exceeds the defined limit under the assay conditions, whereas no clot indicates that the limit was not exceeded.

Its stated uses include pharmaceutical products, biological samples, vaccines, medical devices, and laboratory reagents. In these settings, the assay helps evaluate pyrogen control, support release decisions for injectable medicines, and monitor safety. Applying the same endotoxin-focused readout across these materials makes the technique relevant to both product testing and laboratory quality assessment.

The visible clot is the final output of a biologically derived enzyme cascade, so the method connects molecular recognition with an experimentally accessible observation. Its straightforward endpoint supports routine evaluation of endotoxin in contexts where pyrogen control matters, including injectable medicines and vaccines. It also provides a way to monitor medical devices and reagents for safety.